Comparing ablative fractionated resurfacing, photodynamic therapy, and topical imiquimod in the treatment of trichoblastomas of Brooke-Spiegler Syndrome: A case study

Dermatologic Surgery

Volumn 37, Issue 7, 2011, Pages 1047-1050

  Lopiccolo, Matteo C ^a   Sage, Robert J ^a   Kouba, David J ^a,b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b Toledo Clinic Dermasurgery and Laser Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; CEFALEXIN; IMIQUIMOD; VALACICLOVIR;

ABLATION THERAPY; ABLATIVE FACTIONATED RESURFACING; ADULT; APPLICATION SITE ERYTHEMA; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BROOKE SYNDROME; CASE REPORT; COMPARATIVE STUDY; DISEASE SEVERITY; ERBIUM YAG LASER; FOLLOW UP; HUMAN; IMPETIGO; KAPOSI VARICELLIFORM ERUPTION; MALE; PAIN; PAPULE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CANCER; SKIN NODULE; TELANGIECTASIA; TREATMENT OUTCOME; TRICHOBLASTOMA;

AMINOLEVULINIC ACID; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, ADENOID CYSTIC; CARCINOMA, SKIN APPENDAGE; COMBINED MODALITY THERAPY; HUMANS; LASERS, SOLID-STATE; MALE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 79959843193     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.01907.x     Document Type: Article

References (12)

1. Sima R, Vanecek T, Kacerovska D, et al,. Brooke-Spiegler syndrome: report of 10 patients from 8 families with novel germline mutations; evidence of diverse somatic mutations in the same patient regardless of tumor type. Diagn Mol Pathol 2010; 19: 83-91.
2. Kazakov DV, Soukup R, Mukensnabl P, et al,. Brooke-Spiegler syndrome: report of a case with combined lesions containing cylindromatous, spiradenomatous, trichoblastomatous, and sebaceous differentiation. Am J Dermatopathol 2005; 27: 27-33. (Pubitemid 40189020)
3. Cordoba A, Guerrero D, Larrinaga B, et al,. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation. Int J Dermatol 2009; 48: 713-7.
4. Marmur ES, Schmults CD, Goldberg DJ., A review of laser and photodynamic therapy for the treatment of non-melanoma skin cancer. Dermatol Surg 2004; 30: 264-71. (Pubitemid 38313984)
5. Love WE, Bernhard JD, Bordeaux JS., Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma. Arch Dermatol 2009; 145: 1431-8.
6. Smucler R, Vlk M., Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma. Lasers Surg Med 2008; 40: 153-8. (Pubitemid 351354772)
7. Stoner MF, Hobbs ER., Treatment of multiple dermal cylindromas with the carbon dioxide laser. J Dermatol Surg Oncol 1988; 14: 1263-7. (Pubitemid 19000513)
8. Martins C, Bartolo E., Brooke-Spiegler syndrome: treatment of cylindromas with CO2 laser. Dermatol Surg 2000; 26: 877-81.
9. Tarstedt M, Molin L., Nd:YAG laser for effective treatment of multiple cylindromas of the scalp. J Cosmet Laser Ther 2004; 6: 41-3. (Pubitemid 38661148)
10. Retamar RA, Stengel F, Saadi ME, et al,. Brooke-Spiegler syndrome-report of four families: treatment with CO2 laser. Int J Dermatol 2007; 46: 583-6. (Pubitemid 46909399)
11. Rajan N, Trainer AH, Burn J, Langtry JAA., Familial cylindromatous and Brooke-Spiegler syndrome: a review of current therapeutic approaches and the surgical challenges posed by two affected families. Dermatol Surg 2009; 35: 845-52.
12. Rallan D, Harland CC., Brooke-Spiegler syndrome: treatment with laser ablation. Clin Exp Dermatol 2005; 30: 355-7. (Pubitemid 40835327)